doi: 10.1186/s13063-025-08956-x Summary Keywords cardiac autonomic neuropathy, dapagliflozin, GLP-1 RAs, heart rate variability, T2DM Citation Wang Y, Li H, Zhang Z, Kong X, Li H, Qian W and Ma J (2026) Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study
Nothing in the 2026 proceedings alters that
Imagine it as a gentle hand ironing out a crumpled piece of paper.
Breaks under 4 weeks may allow you to resume your previous dose, while longer breaks typically warrant a gradual restart at a lower dose to minimize side effects
Pierre-Luc Poulin sest fait prescrire de lOzempic dans un objectif de perte de poids en 2021, bien avant que le mdicament devienne si populaire
Leaving vials at room temperature for extended periods